Closure Medical stock surged Thursday on news that the US Food and Drug Administration has approved a new product.

Called “High Viscosity Dermabond Tropical Skin Adhesive,” the Dermabond product is designed for use on curved areas of the body. Closure focuses on medical adhesive brands to close and seal topical skin wounds and incisions. Closure now has some five products on the market.

Closure (Nasdaq: CLSR) says the product will be marketed and sold by Ethicon, a division of Johnson & Johnson. Closure stock was up 65 cents, or 6 percent, to $11.15 in mid-afternoon trading and closed at $11.05, a gain of 5.4 percent on the day.